Neurology
Neurology
Advertisement
Rob DillardDepression | January 23, 2025
The FDA approved esketamine nasal spray for the treatment of adults living with major depressive disorder.
Read More
Rob DillardSleep Disorders | January 13, 2025
Researchers developed an artificial intelligence algorithm that may improve the diagnosis of REM sleep behavior disorder.
Rob DillardDementia | January 8, 2025
A new model called the Florey Dementia Index (FDI) can accurately predict the age at onset of MCI and AD.
Anne Marie Morse, DOSleep Disorders | December 27, 2024
Dr. Anne Morse provides a run-down of the important trends, and therapeutic innovations to occur in sleep medicine this year.
Rob DillardSleep Disorders | December 23, 2024
Dr. Anne Marie Morse provides some gentle reminders for the health implications of over-indulgence during the holidays.
Anne Marie Morse, DOSleep Disorders | December 23, 2024
Dr. Morse defines this "new sleep entity" and how parents can manage it amid the holidays.
Jordana JampelSleep Disorders | December 18, 2024
Intact human brain tissue was used by the researchers.
Jordana JampelDementia | December 18, 2024
The research group will design a vaccine that won't promote inflammation.
Dr. Dimitry SayenkoNeurology | December 2, 2024
Researchers are making significant advancements in spinal neuromodulation for neuromuscular disorders and injuries.
Jordana JampelNeurodivergent | November 26, 2024
This study expands the understanding of the biologic mechanism behind monogenic autism.
Anne Marie Morse, DOSleep Disorders | November 21, 2024
Dr. Anne Marie Morse talks about parasomnias, and how they affect quality of life in people who have them.
Jordana JampelGastroenterology | November 20, 2024
Strict neurologic criteria were applied to the researcher's search strategy.
Jordana JampelNeurodivergent | December 2, 2024
The genetic and environmental implications of air pollutants prompt thoughtful consideration for adapting urban design.
Jordana JampelDementia | December 2, 2024
The phase 2 randomized trial included patients with amyloid-confirmed mild cognitive impairment or early Alzheimer disease.
Mia GriscoNeurology | November 1, 2024
Mia Grisco, a young person living with narcolepsy, shared her perspective on the FDA's recent approval of Avadel's LUMRYZ.
Anne Marie Morse, DOSleep Disorders | November 1, 2024
Dr. Anne Marie Morse breaks down the connection between diet and sleep quality.
Anne Marie Morse, DOSleep Disorders | October 24, 2024
Dr. Anne Marie Morse talks about the significance of the FDA approving LUMRYZ for pediatric patients with narcolepsy.
Rob DillardStroke | December 16, 2024
Recovering stroke patients often endure months or even years of depression driven by factors such as cognitive difficulties.
Rob DillardSleep Disorders | October 17, 2024
The FDA has approved LUMRYZ for the treatment of cataplexy or EDS in patients 7 years of age and older with narcolepsy.
Anne Marie Morse, DOSleep Disorders | October 16, 2024
Dr. Anne Marie Morse spoke in-depth about the connection between screen time and sleep disorders.
Advertisement
Advertisement
Advertisement
Latest News

January 30, 2025